24983LAB0
Dermira Inc
Could not find a ticker for this position, may be a filing error
A biopharmaceutical company that made medicines for skin conditions, Dermira developed Qbrexza, a prescription medicated cloth that eases excessive underarm sweating, and worked on treatments for eczema and acne. Founded in 2010 in Menlo Park, California, its name pairs "derma," the Greek word for skin, with a pharmaceutical-style suffix. The company was acquired by Eli Lilly in 2020.
CONVERTIBLEUnderlying: DERMEURCUSIP: 24983LAB0HealthcareUS1 derivative reporter
3.00% Convertible Senior Notes due 2022
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
